COVID-19 in cancer patients: patient characteristics and outcomes in the post-COVID-19 vaccination period.

Gülşen Iskender Duygu Mert Göknur Yapar Toros Funda Yilmaz Ersin Bozan Semra Tunçbilek Ömür Berna Çakmak Öksüzoğlu Fevzi Altuntaş Mustafa Ertek

Published in: Turkish journal of medical sciences (2023)

This study revealed that there is an increased risk of COVID-19-related serious events (hospitalization, ICU admission, or death) in patients with hematological cancerscompared with those who have solid organ cancers. It wasalso shown that receiving ≥3 doses of COVID-19 vaccine is more protective against severe illness and the need for hospitalization than ≤2 doses.

Keyphrases

coronavirus disease
sars cov
emergency department
intensive care unit
early onset
acute respiratory distress syndrome